Skip to main content

Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Investor Securities Class Action Lawsuit 07/02/2024

  • If you purchased a significant amount of shares of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, and / or if you purchased any NASDAQ: BOLT shares prior to February 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: September 3, 2024. NASDAQ: BOLT investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 02, 2024 - An investor in shares of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Bolt Biotherapeutics, Inc. in connection with certain allegedly false and misleading statements made between February 5, 2021 and May 14, 2024. Redwood City, CA based ...



You must register (for free) or login to view the entire case.